Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 923 of 6351
-
Engineered immune cells and a virus team up against tough cancers
Disease control OngoingThis is a single-center phase 1 study to evaluate the safety and feasibility of huCART-meso cells given in combination with VCN-01 in patients with unresectable or metastatic pancreatic adenocarcinoma and serous epithelial ovarian cancer.
Phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New combo treatment aims to boost stroke recovery
Disease control Recruiting nowThe main objective is to evaluate the efficacy of IV administration of the P2Y12 inhibitor (cangrelor) in addition to mecanich thrombectomy and WMD versus mecanich thrombectomy and WMD alone on the functional prognosis at 3 months, in patients with acute ischemic stroke eligible …
Phase 3 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
MRI screening could catch dangerous prostate cancers years earlier
Diagnosis Recruiting nowThe purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.
Sponsor: University of Chicago • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
New combo aims to tame hairy cell leukemia with fewer side effects
Disease control CompletedThe current standard-of-care for Hairy Cell Leukemia involves chemotherapy, with agents such as cladribine or pentostatin. Chemotherapy is associated with infection, low blood counts and predisposition to future cancers. This study tests a new yet previously validated drug combin…
Phase 2 • Sponsor: Scripps Health • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New triple therapy shows promise for aggressive lung cancer
Disease control OngoingThe purpose of this study was to evaluate the efficacy of low-dose radiotherapy (LDRT) combined with durvalumab, etoposide, and cisplatin/carboplatin in the first-line treatment of extensive-stage small cell lung cancer.
Phase 2 • Sponsor: You Lu • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study aims to make food allergy treatment safer and more tolerable
Disease control Recruiting nowProtocols for Oral Immunotherapy (OIT) for the main food allergens have been recently incorporated in clinical practice for food allergies and their clinical benefits have been acknowledged in European and Canadian official guidelines. There has been some reluctance in both clini…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Gene hunt aims to solve mysterious fetal swelling disorder
Knowledge-focused By invitation onlyNon-immune hydrops fetalis (NIHF) is diagnosed on prenatal ultrasound when abnormal fluid collections are seen in the fetus. NIHF carries significant risks of stillbirth, preterm birth, and postnatal morbidity and mortality, particularly when the etiology remains unknown and crit…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Can a new tracer reveal hidden tumors and metastases?
Diagnosis Recruiting nowTo evaluate the potential usefulness of 68Ga/18F-FAPI positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various FAP-related disease patients.
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo aims to tame rare heart disease
Disease control OngoingThe purpose of this study is to characterize cardiac safety of Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone (D-VCd) treatment regimens (Arm A: daratumumab + immediate VCd treatment and Arm B: daratumumab + deferred VCd) in newly diagnosed systemic amyloid light ch…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New hope for leukemia patients too frail for chemo: triple-drug combo shows promise
Disease control Recruiting nowThis study is to investigate the therapeutic efficacy and side effect of venetoclax, azacytidine combined with chidamide for newly diagnosed acute monocytic leukemia patients that are ineligible for intensive chemotherapy
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New eye drug shows promise in battle against blinding disease
Disease control CompletedThis is a randomised, double-masked, parallel group, multicentre study to evaluate the efficacy and safety of JL14002 compared to Lucentis® in subjects with wAMD.
Phase 3 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
HPV vaccine combo shows promise against head and neck cancer in early trial
Disease control OngoingThe study is open label, phase II clinical trial for the Combination of GX-188E HPV DNA Vaccine with GX-I7 or Pembrolizumab OR the Triple Combination of GX-188E HPV DNA Vaccine, GX-I7, and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 or 18 Positive Head and Nec…
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can a new imaging tracer light up hidden tumors?
Diagnosis Recruiting nowTo evaluate the potential usefulness of 68Ga/18F-Pentixafor/Pentixather positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various CXCR4-related disease patients.
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
Helmet vs. mask vs. oxygen: which keeps patients off breathing tubes?
Disease control Recruiting nowMulticenter, open label, three-arm randomized trial to assess the effect of helmet noninvasive ventilation vs. helmet continuous positive airway pressure vs. high-flow nasal oxygen on the rate of endotracheal intubation of patients with acute moderate-to-severe hypoxemic respirat…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can an immune-boosting drug make chemotherapy more effective against sarcoma?
Disease control OngoingThis study encompasses two multicenter, prospective, open-labeled, 2-arm, non-comparative randomized phase II trials to assess the antitumor activity of bintrafusp alfa in association with doxorubicin
Phase 2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can blood thinners be safer for stroke patients with hidden brain bleeds?
Disease control Recruiting nowTo observe the effect of different antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds. And further combined with proteomic methods to explore serological markers that can be used to accurately predict the prognosis of such patients.
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Which therapy eases back pain disability best? a Head-to-Head trial
Disease control CompletedThe overall aim of the present study is to compare two different psychological methods, Cognitive Behavioural Therapy (CBT) and Graduated Exposure in vivo (EXP) in the treatment of chronic back pain with regard to effectiveness and improvement of pain related disability. Explora…
Sponsor: University of Kaiserslautern-Landau • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new biopsy needle unlock personalized pancreatic cancer therapy?
Diagnosis CompletedSystemic chemotherapy can improve disease-related symptoms and/or prolong survival in patients with pancreatic cancer. Before the start of chemotherapy, the diagnosis pancreatic carcinoma must be confirmed by tumor tissue samples, which are often obtained during endoscopic ultras…
Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated Aug 23, 2026 00:00 UTC
-
New eye drug trial focuses on black, hispanic, and native american patients
Disease control OngoingThis study is designed to investigate treatment response in treatment-naïve underrepresented patients with diabetic macular edema (DME) who are treated with faricimab. The study population will consist of participants ≥18 years of age who self-identify as Black/African American, …
Phase 4 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a dissolving tablet stop migraines in kids?
Disease control Recruiting nowThe purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine.
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC